Meningitis B vaccine (2026)
What the buyer wrote
The provision of a vaccine to protect against meningococcal B (MenB) disease, to be used in the national childhood immunisation programme, as well as a targeted programme to protect at risk adults against Gonorrhoea. This notice provides an indication to the market of UKHSA's intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the meningococcal group B vaccine, in accordance with JCVI advice.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Meningitis B vaccine (2026)
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Work starts
- 30 Sep 2026
- Work ends
- 30 Sep 2028
- Where
- in London
Who the buyer named
The buyer published a contact address on this notice.